Biomerica (BMRA) Current Taxes (2012)

Biomerica's (BMRA) quarterly Current Taxes came in at $19717.0 in Q3 2012, down 67.1% quarter-over-quarter from $59938.0 in Q2 2012.

Biomerica (BMRA) Current Taxes (2012) Analysis & Trends

Biomerica has disclosed Current Taxes across 1 years of filings, most recently posting $19717.0 for Q3 2012.

Current Taxes for Q3 2012 came in at $19717.0, changed N/A year-over-year; the trailing twelve-month figure through Aug 2012 was $19717.0 (changed N/A YoY), and the FY2012 annual result was $59938.0, changed N/A from the prior year.
Current Taxes came in at $19717.0 for Q3 2012 at Biomerica, down from $59938.0 in the prior quarter.
In the past five years, Current Taxes ranged from a high of $59938.0 in Q2 2012 to a low of $19717.0 in Q3 2012.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn	598.00 Mn
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn	476.00 Mn
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn	650.00 Mn
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn	-
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn	-
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn	-
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	231.81 Mn
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn	-
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn	28.60 Mn
10	Biomerica	6.20 Mn	4.87 Mn	-44,000.00	-

Download Data